Pet Recall Facts

Ingredients / Capromorelin

Capromorelin: FDA adverse event reports for pets

Reports received through June 26, 2026. Data and limitations.

2,764Total reports
1,491Dog reports
810Cat reports

FDA-approved products with this ingredient (Green Book)

All approved products with this ingredient, for any species.

Brand names come only from the Green Book. Brand names in FDA's public report data are masked, so counts cannot be attributed to any brand. Ingredient names in the reports are written many ways; we group them under one ingredient name and count each report once per ingredient (method).

Reports by year received

201737
2018284
2019209
2020216
2021335
2022313
2023345
2024383
2025433
2026209

Species named in reports

Dog1,491
Cat810
Not given434
Human23
Rabbit2
Ferret1
Primate1
Mouse1

Signs reported after Capromorelin

Lethargy (see also Central nervous system depression in Neurological)521
Lack of efficacy - NOS389
Vomiting370
Death by euthanasia289
Not eating241
UNPALATABLE207
Hypersalivation205
Diarrhoea200
Death189
Behavioural disorder NOS179
Bradycardia144
Decreased appetite142
Weight loss136
Elevated alanine aminotransferase (ALT)135
Anorexia124
Ataxia111
Hyperglycaemia109
Other abnormal test result NOS108
Elevated blood urea nitrogen (BUN)105
Hypotension101
Drooling97
Elevated total bilirubin96
Anaemia NOS93
Elevated serum alkaline phosphatase (ALP)93
Elevated creatinine87

Breeds named in reports

Dog (unknown)353
Domestic Shorthair350
Cat (unknown)200
Retriever - Labrador107
Crossbred Canine/dog105
Shih Tzu78
Chihuahua76
Domestic Longhair64
Domestic Mediumhair62
Poodle (unspecified)56
Retriever - Golden55
Terrier - Yorkshire52
Shepherd Dog - German42
Maltese37
Terrier (unspecified)33

Reported outcomes

Outcome Unknown801
Recovered/Normal599
Ongoing451
Euthanized286
Died201
Recovered with Sequela2

Report a problem to FDA